TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 74 filers reported holding TRINITY BIOTECH PLC in Q4 2013. The put-call ratio across all filers is 0.45 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $12,950,000 | +16.6% | 979,600 | 0.0% | 3.92% | +18.9% |
| Q2 2016 | $11,109,000 | -2.7% | 979,600 | 0.0% | 3.30% | -26.5% |
| Q1 2016 | $11,422,000 | -2.9% | 979,600 | -2.0% | 4.49% | -25.4% |
| Q4 2015 | $11,760,000 | +10.8% | 1,000,000 | +7.8% | 6.03% | +35.6% |
| Q3 2015 | $10,616,000 | -34.5% | 928,000 | +3.3% | 4.44% | -2.0% |
| Q2 2015 | $16,218,000 | +3.4% | 898,000 | +10.2% | 4.53% | -8.5% |
| Q1 2015 | $15,690,000 | +29.8% | 815,041 | +18.0% | 4.96% | +13.7% |
| Q4 2014 | $12,090,000 | -11.8% | 690,438 | -7.9% | 4.36% | -11.4% |
| Q3 2014 | $13,700,000 | -13.1% | 749,867 | +9.5% | 4.92% | +3.8% |
| Q2 2014 | $15,768,000 | -4.9% | 684,655 | 0.0% | 4.74% | -13.3% |
| Q1 2014 | $16,589,000 | -2.9% | 684,655 | +0.8% | 5.46% | -3.0% |
| Q4 2013 | $17,078,000 | +16.8% | 679,300 | +1.1% | 5.63% | +0.1% |
| Q3 2013 | $14,625,000 | +32.1% | 672,100 | +2.3% | 5.62% | +25.3% |
| Q2 2013 | $11,072,000 | – | 657,100 | – | 4.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lyon Street Capital, LLC | 739,669 | $13,514,000 | 6.33% |
| ACK Asset Management | 749,867 | $13,700,000 | 4.92% |
| CASTLEROCK ASSET MANAGEMENT INC | 26,751 | $489,000 | 4.12% |
| GOLDMAN CAPITAL MANAGEMENT INC | 309,297 | $5,651,000 | 2.83% |
| Paradice Investment Management LLC | 348,686 | $6,370,000 | 1.66% |
| Park West Asset Management LLC | 600,770 | $10,976,000 | 1.62% |
| Adirondack Research & Management Inc. | 220,638 | $4,031,000 | 1.50% |
| RK Capital | 375,043 | $6,852,000 | 1.40% |
| KEANE CAPITAL MANAGEMENT INC | 70,000 | $1,279,000 | 1.23% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 953,618 | $17,423,000 | 1.08% |